Evaluation of a medication history and reconciliation prior-to-admission acuity score for association with clinically relevant interventions
Purpose Pharmacy-led admission medication history taking and reconciliation optimizes medication therapy and reduces errors. A prior-to-admission (PTA) acuity score can identify patients who benefit from timely, pharmacy-led medication reconciliations based on patient-specific factors and high-risk PTA medications. This study evaluated the association of PTA acuity scores with the number of clinically relevant interventions. Methods This retrospective cohort study included inpatient encounters from January 1 through March 31, 2025, that involved a documented pharmacy-led admission medication reconciliation. Data for each encounter included additions, deletions, and edits by a pharmacy user to the PTA list. Prescription medications and over-the-counter (OTC) aspirin and proton pump inhibitors were considered clinically relevant medications. Additions, deletions, or edits that changed the total daily dose by at least 20% were considered clinically relevant. The primary outcome was to evaluate the distribution of clinically relevant interventions across PTA acuity score groups. Results Of the 4,798 patient encounters included, 68% required changes and 61% required clinically relevant changes. There was a median of 2 changes per encounter (IQR, 0-5), and a median of 1 clinically relevant change per encounter (IQR, 0-4). The frequency of changes and clinically relevant changes increased with a rising PTA score. There were significant differences in the number of relevant changes between all PTA score groups (P < 0.001) and the incidence of at least 1 clinically relevant change (P < 0.001). Conclusion This study demonstrates higher medication history and reconciliation PTA acuity scores are associated with more interventions and a greater number of clinically relevant interventions.
Authors
- Kevin T. Kissling (ORCID: https://orcid.org/0000-0003-4408-5512)
- Charlotte M. Forshay (ORCID: https://orcid.org/0000-0003-2204-113X)
- Joshua W. Gaborcik
- John Mellett (ORCID: https://orcid.org/0000-0001-6469-5698)
- Fadwa Constandinidis Revelos
- Danielle M. Blais
- Claire Joseph (ORCID: https://orcid.org/0009-0007-0323-2295)
Institutions
- The Ohio State University Wexner Medical Center (US)
- The Ohio State University (US)
Publication Details
- Journal
- American Journal of Health-System Pharmacy
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1093/ajhp/zxag408
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00